PF-00217830 Uses, Dosage, Side Effects and more
PF-00217830 has been used in trials studying the treatment of Schizophrenia.
| Attribute | Details |
|---|---|
| Trade Name | PF-00217830 |
| Generic | PF-00217830 |
| Type | |
| Formula | C26H30N4O2 |
| Weight | Average: 430.552 Monoisotopic: 430.236876222 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
